Immix Biopharma (IMMX) Times Interest Earned (2021 - 2022)
Immix Biopharma's (IMMX) quarterly Times Interest Earned came in at -$14320.7 in Q2 2022, down 317126.32% year-on-year from N/an in Q2 2021, and down 317.76% quarter-over-quarter from -$3427.9 in Q1 2022.
Immix Biopharma (IMMX) Times Interest Earned (2021 - 2022) Analysis & Trends
Immix Biopharma has disclosed Times Interest Earned across 2 years of filings, most recently posting -$14320.7 for Q2 2022.
- Times Interest Earned for Q2 2022 came in at -$14320.7, down 317126.32% year-over-year; the trailing twelve-month figure through Mar 2023 was -$86327.2 (down 523088.57% YoY), and the FY2022 annual result was -$16537.1, down 219886.66% from the prior year.
- Times Interest Earned came in at -$14320.7 for Q2 2022 at Immix Biopharma, down from -$3427.9 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of -$4.51 in Q2 2021 to a low of -$14320.7 in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 3.58 |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -258.33 |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | 11.50 |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | - |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | 11.79 |
| 10 | Immix Biopharma | 467.59 Mn | 467.59 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | -14,320.68 |
| Mar 31, 2022 | -3,427.93 |
| Dec 31, 2021 | -13.44 |
| Sep 30, 2021 | -6.45 |
| Jun 30, 2021 | -4.51 |
| Mar 31, 2021 | -5.90 |